Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Eli Lilly and Company
Pfizer
Pfizer
Tomsk National Research Medical Center of the Russian Academy of Sciences
M.D. Anderson Cancer Center
Eisai Inc.
Erasca, Inc.
Incyte Corporation
Genentech, Inc.
Poseida Therapeutics, Inc.
Novartis
Astellas Pharma Inc
M.D. Anderson Cancer Center
Seagen Inc.
Seagen Inc.
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
AgonOx, Inc.
Peking University Cancer Hospital & Institute
Novartis
Amgen
Bristol-Myers Squibb
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
HiFiBiO Therapeutics
Enliven Therapeutics
National Cancer Institute (NCI)
AbbVie
Tesaro, Inc.
TORL Biotherapeutics, LLC
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
HUYABIO International, LLC.
HUYABIO International, LLC.
M.D. Anderson Cancer Center
Valo Therapeutics Oy
Exelixis
Toray Industries, Inc
DEKA Biosciences
AbbVie
Carisma Therapeutics Inc
Exelixis
Revolution Medicines, Inc.
National Cancer Institute (NCI)
NGM Biopharmaceuticals, Inc
RemeGen Co., Ltd.
Ono Pharmaceutical Co. Ltd
NantBioScience, Inc.
Adlai Nortye Biopharma Co., Ltd.
NGM Biopharmaceuticals, Inc